Log In
BCIQ
Print this Print this
 

PF-06342674, RN168

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today